Roivant Sciences Ltd

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Roivant Sciences Ltd
TickerROIV
CIK #0001635088
CUSIPG76279101
SectorLife Sciences - Pharmaceutical Preparations
AddressClarendon House, 2 Church Street, Hamilton Hm11, HM11
Source [EDGAR]
CIK Filing 2011 - 2025
[0001635088] 10-K
[0001635088] 10-Q
[0001635088] 3
[0001635088] 4
[0001635088] 8-K
[0001635088] SC 13D
[0001635088] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Morgan Stanley Roivant Sciences Ltd [2025-08-07] 0.0
FMR LLC Roivant Sciences Ltd [2024-11-12] 0.0
BlackRock Inc Roivant Sciences Ltd [2024-11-08] 5.7
BlackRock Inc Roivant Sciences Ltd [2024-10-24] 5.7
QVT Financial LP Roivant Sciences Ltd [2022-02-14] 18.7
Ramaswamy Vivek Roivant Sciences Ltd [2022-02-14] 10.5
SB Investment Advisers UK Ltd Roivant Sciences Ltd [2022-02-14] 14.4
Viking Global Investors LP Roivant Sciences Ltd [2022-02-14] 12.8
Dexcel Pharma Technologies Ltd Roivant Sciences Ltd [2022-02-10] 0.093
Sumitomo Chemical Co Ltd Roivant Sciences Ltd [2022-02-01] 12.48
Roivant Sciences Ltd Immunovant Inc [2019-12-20] 66.3
Roivant Sciences Ltd Myovant Sciences Ltd [2019-06-14] 45.6
Roivant Sciences Ltd Urovant Sciences Ltd [2018-10-10] 75.6
Roivant Sciences Ltd Axovant Sciences Ltd [2018-06-15] 73.1
Roivant Sciences Ltd Myovant Sciences Ltd [2017-02-10] 61.8
Roivant Sciences Ltd Axovant Sciences Ltd [2016-02-16] 75.6
Roivant Sciences Ltd Tekmira Pharmaceuticals Corp [2015-03-16] 34.4
Form 3/4/5 Filer 2011 - 2025
Roivant Sciences Ltd.
Venker Eric
Torti Frank
Pulik Richard
Momtazee James C
Epperly Melissa B,
Oren Ilan
Manchester Keith S
Gold Daniel Allen
QVT Financial LP
Ramaswamy Vivek
Gline Matthew
Humes Jennifer
Kumar Rakhi
Immunovant, Inc.
Sukhatme Mayukh
Fitzgerald Meghan
SoftBank Vision Fund L.P.
SB Investment Advisers UK Ltd
SVF Investments (UK) Ltd
SVF Holdings (UK) LLP
Viking Global Opportunities Portfolio GP LLC
Viking Global Opportunities Illiquid Investments Sub-Master
Viking Global Opportunities Parent GP LLC
Halvorsen Ole Andreas
Ott David C.
Shabet Rose Sharon
Viking Global Opportunities GP LLC
Viking Global Investors LP
Viking Global Equities Master Ltd.
Viking Long Fund Master Ltd.
Viking Long Fund GP LLC
Viking Global Performance LLC
Viking Global Equities II LP
Sumitomo Chemical Co., Ltd.
Sumitomo Pharma Co., Ltd.
Oren Dan
Dexcel Pharma Technologies Ltd.
Dexxon Holdings Ltd.
Nomura Hiroshi
Lo Andrew
Arbutus Biopharma Corp
QVT Financial GP LLC
Machado Patrick
Zimmer Benjamin
Tada Masayo
SVF GP (Jersey) Ltd
Sio Gene Therapies Inc.
Urovant Sciences Ltd.
Myovant Sciences Ltd.
Form 13F Holdings
Firm Period DFND Voting Shares
SB Investment Advisers UK Ltd [2025-06-30] SOLE 59,952,652 59,952,652
FMR LLC [2025-06-30] DFND 55,467,163 55,509,281
Morgan Stanley [2025-06-30] DFND 41,230,847 44,693,966
BlackRock, Inc. [2025-06-30] SOLE 38,762,920 40,316,307
Vanguard Group Inc [2025-06-30] SOLE 0 38,707,302
Viking Global Investors LP [2025-06-30] SOLE 34,237,779 34,237,779
QVT Financial LP [2025-06-30] DFND 29,381,635 29,381,635
Rubric Capital Management LP [2025-06-30] SOLE 20,370,336 20,370,336
State Street Corp [2025-06-30] DFND 18,680,617 19,773,480
Patient Square Capital LP [2025-06-30] SOLE 12,480,000 12,480,000
Two SEAS Capital LP [2025-06-30] SOLE 10,598,040 10,598,040
Geode Capital Management LLC [2025-06-30] DFND 7,674,062 7,750,399
Dimensional Fund Advisors LP [2025-06-30] SOLE 6,061,112 6,644,869
UBS Group AG [2025-06-30] DFND 5,092,598 5,093,068
Anchorage Capital Group LLC [2025-06-30] SOLE 4,832,642 4,832,642
Blackbarn Capital Partners LP [2025-06-30] SOLE 4,625,000 4,625,000
Bank of New York Mellon Corp [2025-06-30] DFND 4,263,176 4,503,095
Sofinnova Investments Inc [2025-06-30] SOLE 4,088,814 4,088,814
Woodline Partners LP [2025-06-30] SOLE 4,000,033 4,000,033
Whitefort Capital Management LP [2025-06-30] SOLE 3,882,000 3,882,000
Baker Bros Advisors LP [2025-06-30] SOLE 3,767,773 3,767,773
DME Capital Management LP [2025-06-30] SOLE 3,371,387 3,371,387
Toms Capital Investment Management LP [2025-06-30] SOLE 3,180,800 3,340,000
Perceptive Advisors LLC [2025-06-30] SOLE 3,331,465 3,331,465
Pertento Partners LLP [2025-06-30] SOLE 3,104,361 3,104,361
Northern Trust Corp [2025-06-30] DFND 3,008,902 3,027,978
Point72 Asset Management LP [2025-06-30] DFND 0 2,951,132
Goldman Sachs Group Inc [2025-06-30] DFND 2,867,099 2,937,367
Charles Schwab Investment Management Inc [2025-06-30] SOLE 2,889,045 2,889,082
OrbiMed Advisors LLC [2025-06-30] DFND 439,129 2,779,427
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com